Real-World Outcomes of Treating Advanced Breast Cancer Patients With Palbociclib: A Multicenter Retrospective Cohort Study in Japan-The KBCOG-14 Study.

Nina OdanYuichiro KikawaHajime MatsumotoJunya MinohataHirofumi SuwaTakashi HashimotoToshitaka OkunoMasaru MiyashitaMasaru SaitoKazuhiko YamagamiShintaro Takao

Published in: Breast cancer : basic and clinical research (2020)

Based on the results of the pivotal phase 3 trials, the median TTD recorded in this study was shorter than expected. Our results suggest that liver metastasis, serum LDH level, and NLR may be predictive factors for HR+/HER2- ABC treatment outcomes.

Keyphrases

type diabetes
young adults
cross sectional
metabolic syndrome
metastatic breast cancer
double blind